Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients.

Levin MJ, Bacon TH, Leary JJ.

Clin Infect Dis. 2004 Nov 1;39 Suppl 5:S248-57. Review.

PMID:
15494896
2.

Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials.

Sarisky RT, Bacon TH, Boon RJ, Duffy KE, Esser KM, Leary J, Locke LA, Nguyen TT, Quail MR, Saltzman R.

Arch Virol. 2003 Sep;148(9):1757-69.

PMID:
14505088
3.

Susceptibility of herpes simplex virus isolates to nucleoside analogues and the proportion of nucleoside-resistant variants after repeated topical application of penciclovir to recurrent herpes labialis.

Shin YK, Weinberg A, Spruance S, Bernard M, Bacon TH, Boon RJ, Levin MJ.

J Infect Dis. 2003 Apr 15;187(8):1241-5. Epub 2003 Mar 26.

PMID:
12696003
4.

Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy.

Bacon TH, Levin MJ, Leary JJ, Sarisky RT, Sutton D.

Clin Microbiol Rev. 2003 Jan;16(1):114-28. Review.

5.

Surveillance for antiviral-agent-resistant herpes simplex virus in the general population with recurrent herpes labialis.

Bacon TH, Boon RJ, Schultz M, Hodges-Savola C.

Antimicrob Agents Chemother. 2002 Sep;46(9):3042-4.

6.

Analgesic efficacy of sustained release paracetamol in patients with osteoarthritis of the knee.

Bacon TH, Hole JG, North M, Burnett I.

Br J Clin Pharmacol. 2002 Jun;53(6):629-36.

7.

Assessing the contribution of the herpes simplex virus DNA polymerase to spontaneous mutations.

Duffy KE, Quail MR, Nguyen TT, Wittrock RJ, Bartus JO, Halsey WM, Leary JJ, Bacon TH, Sarisky RT.

BMC Infect Dis. 2002 May 7;2:7.

8.

Absence of rapid selection for acyclovir or penciclovir resistance following suboptimal oral prodrug therapy of HSV-infected mice.

Sarisky RT, Bartus HR, Dennis SA, Quail MR, Nguyen TT, Wittrock RJ, Halsey WS, Bacon TH, Leary JJ, Sutton D.

BMC Infect Dis. 2001;1:24. Epub 2001 Dec 10.

9.

Biochemical characterization of a virus isolate, recovered from a patient with herpes keratitis, that was clinically resistant to acyclovir.

Sarisky RT, Cano R, Nguyen TT, Wittrock RJ, Duffy KE, Clark P, Bartus JO, Bacon TH, Caspers-Velu L, Hodinka RL, Leary JJ.

Clin Infect Dis. 2001 Dec 15;33(12):2034-9. Epub 2001 Nov 14.

PMID:
11712095
10.

Comparison of methods for identifying resistant herpes simplex virus and measuring antiviral susceptibility.

Sarisky RT, Crosson P, Cano R, Quail MR, Nguyen TT, Wittrock RJ, Bacon TH, Sacks SL, Caspers-Velu L, Hodinka RL, Leary JJ.

J Clin Virol. 2002 Jan;23(3):191-200.

PMID:
11595598
11.
12.

Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.

Sarisky RT, Quail MR, Clark PE, Nguyen TT, Halsey WS, Wittrock RJ, O'Leary Bartus J, Van Horn MM, Sathe GM, Van Horn S, Kelly MD, Bacon TH, Leary JJ.

J Virol. 2001 Feb;75(4):1761-9.

13.

Antiviral susceptibilities of herpes simplex virus from immunocompetent subjects with recurrent herpes labialis: a UK-based survey.

Boon RJ, Bacon TH, Robey HL, Coleman TJ, Connolly A, Crosson P, Sacks SL.

J Antimicrob Chemother. 2000 Dec;46(6):1051. No abstract available.

PMID:
11102435
14.
15.

Antiviral susceptibilities of herpes simplex virus from immunocompetent subjects with recurrent herpes labialie: a UK-based survey.

Boon RJ, Bacon TH, Robey HL, Coleman TJ, Connolly A, Crosson P, Sacks SL.

J Antimicrob Chemother. 2000 Aug;46(2):324-5. No abstract available.

PMID:
10933664
16.

Famciclovir, from the bench to the patient--a comprehensive review of preclinical data.

Bacon TH.

Int J Antimicrob Agents. 1996 Jul;7(2):119-34.

PMID:
18611746
17.

Activity of penciclovir in antiviral assays against herpes simplex virus.

Bacon TH, Howard BA, Spender LC, Boyd MR.

J Antimicrob Chemother. 1996 Feb;37(2):303-13.

PMID:
8707740
19.

Activity of penciclovir against Epstein-Barr virus.

Bacon TH, Boyd MR.

Antimicrob Agents Chemother. 1995 Jul;39(7):1599-602.

20.

Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus.

Earnshaw DL, Bacon TH, Darlison SJ, Edmonds K, Perkins RM, Vere Hodge RA.

Antimicrob Agents Chemother. 1992 Dec;36(12):2747-57.

21.

Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine (BRL 39123) in animals.

Boyd MR, Bacon TH, Sutton D.

Antimicrob Agents Chemother. 1988 Mar;32(3):358-63.

22.

Synthesis and antiviral activity of 9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]purines.

Harnden MR, Jarvest RL, Bacon TH, Boyd MR.

J Med Chem. 1987 Sep;30(9):1636-42.

PMID:
3040998
23.

Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture.

Boyd MR, Bacon TH, Sutton D, Cole M.

Antimicrob Agents Chemother. 1987 Aug;31(8):1238-42.

24.

Changes in the populations of lymphoid cells in human peripheral blood following physical exercise.

Edwards AJ, Bacon TH, Elms CA, Verardi R, Felder M, Knight SC.

Clin Exp Immunol. 1984 Nov;58(2):420-7.

25.

Interferon-gamma production by peripheral blood mononuclear cells from patients with Beh├žet's syndrome.

Bacon TH, Ozbakir F, Elms CA, Denman AM.

Clin Exp Immunol. 1984 Sep;57(3):541-7.

26.

Interferon system in patients with systemic juvenile chronic arthritis: in vivo and in vitro studies.

Bacon TH, de Vere-Tyndall A, Tyrrell DA, Denman AM, Ansell BM.

Clin Exp Immunol. 1983 Oct;54(1):23-30.

Supplemental Content

Loading ...
Support Center